• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1990 - 2019年吸烟导致的全球癌症负担:一项生态学研究

Global burden of cancers attributable to tobacco smoking, 1990-2019: an ecological study.

作者信息

Sharma Rajesh, Rakshit Bijoy

机构信息

Humanities and Social Sciences, National Institute of Technology Kurukshetra, Kurukshetra, India.

Economics and Business Environment, Indian Institute of Management Jammu, Jammu and Kashmir, India.

出版信息

EPMA J. 2022 Dec 15;14(1):167-182. doi: 10.1007/s13167-022-00308-y. eCollection 2023 Mar.

DOI:10.1007/s13167-022-00308-y
PMID:36866162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9971393/
Abstract

AIM AND BACKGROUND

Identifying risk factors for cancer initiation and progression is the cornerstone of the preventive approach to cancer management and control (EPMA J. 4(1):6, 2013). Tobacco smoking is a well-recognized risk factor for initiation and spread of several cancers. The predictive, preventive, and personalized medicine (PPPM) approach to cancer management and control focuses on smoking cessation as an essential cancer prevention strategy. Towards this end, this study examines the temporal patterns of cancer burden due to tobacco smoking in the last three decades at global, regional, and national levels.

DATA AND METHODS

The data pertaining to the burden of 16 cancers attributable to tobacco smoking at global, regional, and national levels were procured from the Global Burden of Disease 2019 Study. Two main indicators, deaths and disability-adjusted life years (DALYs), were used to describe the burden of cancers attributable to tobacco smoking. The socio-economic development of countries was measured using the socio-demographic index (SDI).

RESULTS

Globally, deaths due to neoplasms caused by tobacco smoking increased from 1.5 million in 1990 to 2.5 million in 2019, whereas the age-standardized mortality rate (ASMR) decreased from 39.8/100,000 to 30.6/100,000 and the age-standardized DALY rate (ASDALR) decreased from 948.9/100,000 to 677.3/100,000 between 1990 and 2019. Males accounted for approximately 80% of global deaths and DALYs in 2019. Populous regions of Asia and a few regions of Europe account for the largest absolute burden, whereas countries in Europe and America have the highest age-standardized rates of cancers due to tobacco smoking. In 8 out of 21 regions, there were more than 100,000 deaths due to cancers attributable to tobacco smoking led by East Asia, followed by Western Europe in 2019. The regions of Sub-Saharan Africa (except southern region) had one of the lowest absolute counts of deaths, DALYs, and age-standardized rates. In 2019, tracheal, bronchus, and lung (TBL), esophageal, stomach, colorectal, and pancreatic cancer were the top 5 neoplasms attributable to tobacco smoking, with different burdens in regions as per their development status. The ASMR and ASDALR of neoplasms due to tobacco smoking were positively correlated with SDI, with pairwise correlation coefficient of 0.55 and 0.52, respectively.

CONCLUSION

As a preventive tool, tobacco smoking cessation has the biggest potential among all risk factors for preventing millions of cancer deaths every year. Cancer burden due to tobacco smoking is found to be higher in males and is positively associated with socio-economic development of countries. As tobacco smoking begins mostly at younger ages and the epidemic is unfolding in several parts of the world, more accelerated efforts are required towards tobacco cessation and preventing youth from entering this addiction. The PPPM approach to medicine suggests that not only personalized and precision medicine must be provided to cancer patients afflicted by tobacco smoking but personalized and targeted preventive solutions must be provided to prevent initiation and progression of smoking.

SUPPLEMENTARY INFORMATION

The online version contains supplementary material available at 10.1007/s13167-022-00308-y.

摘要

目的与背景

识别癌症发生和进展的风险因素是癌症管理与控制预防方法的基石(《欧洲精准医学杂志》,2013年,第4卷第1期,第6页)。吸烟是几种癌症发生和扩散的公认风险因素。癌症管理与控制的预测、预防和个性化医疗(PPPM)方法将戒烟作为一项重要的癌症预防策略。为此,本研究在全球、区域和国家层面考察了过去三十年吸烟导致的癌症负担的时间模式。

数据与方法

从《2019年全球疾病负担研究》中获取了全球、区域和国家层面与16种吸烟所致癌症负担相关的数据。使用两个主要指标,即死亡人数和伤残调整生命年(DALYs)来描述吸烟所致癌症的负担。使用社会人口指数(SDI)衡量各国的社会经济发展情况。

结果

在全球范围内,吸烟所致肿瘤死亡人数从1990年的150万增加到2019年的250万,而年龄标准化死亡率(ASMR)从1990年的39.8/10万降至2019年的30.6/10万,年龄标准化伤残调整生命年率(ASDALR)从948.9/10万降至677.3/10万。2019年,男性约占全球死亡人数和伤残调整生命年的80%。亚洲人口众多的地区和欧洲的一些地区负担的绝对数量最大,而欧洲和美洲国家吸烟所致癌症的年龄标准化率最高。在21个地区中的8个地区,2019年因吸烟所致癌症死亡人数超过10万,其中东亚居首,其次是西欧。撒哈拉以南非洲地区(南部地区除外)的死亡人数、伤残调整生命年和年龄标准化率的绝对数量是最低的之一。2019年,气管、支气管和肺癌(TBL)、食管癌、胃癌、结直肠癌和胰腺癌是吸烟所致的前5种肿瘤,根据各地区的发展状况,其负担情况有所不同。吸烟所致肿瘤的年龄标准化死亡率和年龄标准化伤残调整生命年率与社会人口指数呈正相关,成对相关系数分别为0.55和0.52。

结论

作为一种预防手段,戒烟在所有风险因素中具有最大潜力,每年可预防数百万癌症死亡。吸烟所致癌症负担在男性中更高,且与各国的社会经济发展呈正相关。由于吸烟大多始于年轻时,且这种流行在世界多个地区仍在发展,因此需要加快努力戒烟,并防止年轻人染上这种瘾。PPPM医学方法表明,不仅要为受吸烟影响的癌症患者提供个性化和精准医疗,还必须提供个性化和有针对性的预防解决方案,以防止吸烟的发生和进展。

补充信息

网络版包含可在10.1007/s13167-022-00308-y获取的补充材料。

相似文献

1
Global burden of cancers attributable to tobacco smoking, 1990-2019: an ecological study.1990 - 2019年吸烟导致的全球癌症负担:一项生态学研究
EPMA J. 2022 Dec 15;14(1):167-182. doi: 10.1007/s13167-022-00308-y. eCollection 2023 Mar.
2
Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年男性归因于吸烟的前列腺癌全球负担。
BMC Cancer. 2023 Jan 26;23(1):92. doi: 10.1186/s12885-023-10552-8.
3
Burden of Stomach Cancer Incidence, Mortality, Disability-Adjusted Life Years, and Risk Factors in 204 Countries, 1990-2019: An Examination of Global Burden of Disease 2019.204 个国家 1990-2019 年胃癌发病、死亡、伤残调整生命年及危险因素负担:2019 年全球疾病负担研究
J Gastrointest Cancer. 2024 Jun;55(2):787-799. doi: 10.1007/s12029-023-01005-3. Epub 2024 Jan 24.
4
Global, regional, and national burden of respiratory tract cancers and associated risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019.全球、区域和国家的呼吸道癌症负担及相关风险因素:2019 年全球疾病负担研究的系统分析。
Lancet Respir Med. 2021 Sep;9(9):1030-1049. doi: 10.1016/S2213-2600(21)00164-8. Epub 2021 Aug 16.
5
Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019.204 个国家和地区 1990-2019 年归因于烟草使用的癌症全球、区域和国家负担。
Cancer Med. 2022 Jul;11(13):2662-2678. doi: 10.1002/cam4.4647. Epub 2022 May 27.
6
Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study.全球、区域和国家层面气管、支气管和肺癌的流行病学趋势:一项基于人群的研究。
J Hematol Oncol. 2020 Jul 20;13(1):98. doi: 10.1186/s13045-020-00915-0.
7
Global burden of esophageal cancer attributable to smoking: a systematic analysis for the Global Burden of Disease Study 2019.归因于吸烟的食管癌全球负担:2019年全球疾病负担研究的系统分析
Front Oncol. 2023 Aug 9;13:1223164. doi: 10.3389/fonc.2023.1223164. eCollection 2023.
8
Global burden of chronic obstructive pulmonary disease attributable to ambient ozone in 204 countries and territories during 1990-2019.1990 - 2019年期间204个国家和地区因环境臭氧导致的慢性阻塞性肺疾病全球负担
Environ Sci Pollut Res Int. 2022 Feb;29(6):9293-9305. doi: 10.1007/s11356-021-16233-y. Epub 2021 Sep 9.
9
The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年归因于环境细颗粒物的全球疾病负担:2019 年全球疾病负担研究的系统分析。
Ecotoxicol Environ Saf. 2022 Jun 15;238:113588. doi: 10.1016/j.ecoenv.2022.113588. Epub 2022 May 5.
10
Global burden of tracheal, bronchus, and lung cancer attributable to occupational carcinogens in 204 countries and territories, from 1990 to 2019: results from the global burden of disease study 2019.204 个国家和地区 1990 年至 2019 年归因于职业致癌物的气管、支气管和肺癌全球负担:2019 年全球疾病负担研究结果。
Ann Med. 2023 Dec;55(1):2206672. doi: 10.1080/07853890.2023.2206672.

引用本文的文献

1
Burden and Future Trends of Gastric Cancer in 5 East Asian Countries From 1990 to 2036: Epidemiological Study Analysis Using the Global Burden of Diseases Study 2021.1990年至2036年东亚5国胃癌负担及未来趋势:利用2021年全球疾病负担研究进行的流行病学研究分析
JMIR Cancer. 2025 Sep 3;11:e74389. doi: 10.2196/74389.
2
Effects of Nicotine-Free E-Cigarettes on Gastrointestinal System: A Systematic Review.不含尼古丁的电子烟对胃肠道系统的影响:一项系统综述
Biomedicines. 2025 Aug 16;13(8):1998. doi: 10.3390/biomedicines13081998.
3
Causal associations between smoking and ocular diseases: a Mendelian randomization study.吸烟与眼部疾病之间的因果关联:一项孟德尔随机化研究。
Adv Ophthalmol Pract Res. 2025 Jun 14;5(3):220-225. doi: 10.1016/j.aopr.2025.06.002. eCollection 2025 Aug-Sep.
4
Global impact of dietary risks on cancers: burdens across regions from 1990 to 2021 and the projection to 2035.饮食风险对癌症的全球影响:1990年至2021年各地区负担及到2035年的预测
Front Nutr. 2025 Jul 4;12:1585305. doi: 10.3389/fnut.2025.1585305. eCollection 2025.
5
Global burden of kidney cancer attributable to smoking: A systematic analysis of the 1990-2021 global burden of disease study.归因于吸烟的肾癌全球负担:对1990 - 2021年全球疾病负担研究的系统分析
Prev Med Rep. 2025 May 2;54:103096. doi: 10.1016/j.pmedr.2025.103096. eCollection 2025 Jun.
6
Burden of smoking-related stroke in Saudi Arabia: trends from 1990 to 2021.沙特阿拉伯吸烟相关中风的负担:1990年至2021年的趋势
PLoS One. 2025 May 28;20(5):e0324039. doi: 10.1371/journal.pone.0324039. eCollection 2025.
7
Risk Factors and Prevention of Cancer and CVDs: A Chicken and Egg Situation.癌症和心血管疾病的风险因素及预防:先有鸡还是先有蛋的问题。
J Clin Med. 2025 Apr 29;14(9):3083. doi: 10.3390/jcm14093083.
8
A comparative analysis of the burden, trends and inequalities of tracheal, bronchus, and lung cancer in India from 2000 to 2021: A systematic analysis for the Global Burden of Disease study 2021.2000年至2021年印度气管、支气管和肺癌负担、趋势及不平等的比较分析:2021年全球疾病负担研究的系统分析
PLoS One. 2025 May 7;20(5):e0322646. doi: 10.1371/journal.pone.0322646. eCollection 2025.
9
Association between serum cotinine and muscle mass: results from NHANES 2011-2018.血清可替宁与肌肉量的关系:来自 NHANES 2011-2018 的结果。
BMC Public Health. 2024 Aug 2;24(1):2093. doi: 10.1186/s12889-024-19623-2.
10
The Product Science of Electrically Heated Tobacco Products: An Updated Narrative Review of the Scientific Literature.加热烟草制品的产品科学:科学文献的最新叙述性综述
Cureus. 2024 May 28;16(5):e61223. doi: 10.7759/cureus.61223. eCollection 2024 May.

本文引用的文献

1
TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.从预测、预防和个性化医疗的角度来看,TMEM92在胰腺癌中作为一种免疫抵抗和预后标志物发挥作用。
EPMA J. 2022 Jul 4;13(3):519-534. doi: 10.1007/s13167-022-00287-0. eCollection 2022 Sep.
2
Risk Factors of Relapse After Smoking Cessation: Results in China Family Panel Studies From 2010 to 2018.戒烟后复吸的风险因素:来自 2010 年至 2018 年中国家庭面板研究的结果。
Front Public Health. 2022 Jul 1;10:849647. doi: 10.3389/fpubh.2022.849647. eCollection 2022.
3
Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.预测、预防和个性化医学框架下的抗前列腺癌保护与治疗——植物化学物质在一级、二级和三级医疗中的综合作用
EPMA J. 2022 Jul 8;13(3):461-486. doi: 10.1007/s13167-022-00288-z. eCollection 2022 Sep.
4
Anti-breast cancer effects of phytochemicals: primary, secondary, and tertiary care.植物化学物质的抗乳腺癌作用:初级、二级和三级护理。
EPMA J. 2022 Apr 14;13(2):315-334. doi: 10.1007/s13167-022-00277-2. eCollection 2022 Jun.
5
Involvement of m6A regulatory factor IGF2BP1 in malignant transformation of human bronchial epithelial Beas-2B cells induced by tobacco carcinogen NNK.m6A调控因子IGF2BP1参与烟草致癌物NNK诱导的人支气管上皮Beas-2B细胞恶性转化
Toxicol Appl Pharmacol. 2022 Feb 1;436:115849. doi: 10.1016/j.taap.2021.115849. Epub 2021 Dec 30.
6
Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019: A Systematic Analysis for the Global Burden of Disease Study 2019.2010 年至 2019 年 29 种癌症的发病率、死亡率、生命损失年数、失能生存年数和伤残调整生命年:2019 年全球疾病负担研究的系统分析。
JAMA Oncol. 2022 Mar 1;8(3):420-444. doi: 10.1001/jamaoncol.2021.6987.
7
N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer.N6-甲基腺苷相关的非编码RNA是膀胱癌潜在的预后和免疫治疗反应性生物标志物。
EPMA J. 2021 Oct 21;12(4):589-604. doi: 10.1007/s13167-021-00259-w. eCollection 2021 Dec.
8
Personalization of medical treatments in oncology: time for rethinking the disease concept to improve individual outcomes.肿瘤学中医疗治疗的个性化:是时候重新思考疾病概念以改善个体治疗结果了。
EPMA J. 2021 Oct 7;12(4):545-558. doi: 10.1007/s13167-021-00254-1. eCollection 2021 Dec.
9
Extended cost-benefit analysis of tobacco taxation in Brazil.巴西烟草税收的扩展成本效益分析。
Tob Control. 2022 Sep;31(Suppl 2):s74-s79. doi: 10.1136/tobaccocontrol-2021-056806. Epub 2021 Oct 4.
10
Personality-targeted prevention for adolescent tobacco use: Three-year outcomes for a randomised trial in Australia.人格导向预防青少年吸烟:澳大利亚一项随机试验的 3 年结果。
Prev Med. 2021 Dec;153:106794. doi: 10.1016/j.ypmed.2021.106794. Epub 2021 Sep 8.